Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracameral Antibiotic Safety Study
NCT02590523Phase 3Suspended
- Sponsor
- Panhandle Eye Group
- Start
- Jan 2023
- Primary completion
- Jan 2024
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of vancomycin, moxifloxacin in endophthalmitis, sponsored by Panhandle Eye Group. Started Jan 2023; status: suspended.
02
Drugs
vancomycinmoxifloxacin
03
Conditions
endophthalmitis
Beyond the preview
Go deeper on NCT02590523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02590523.